The function of peroxisome proliferator-activated receptors PPAR-γ and PPAR-δ in Mycobacterium leprae-induced foam cell formation in host macrophages

PLoS Negl Trop Dis. 2020 Oct 19;14(10):e0008850. doi: 10.1371/journal.pntd.0008850. eCollection 2020 Oct.

Abstract

Leprosy is a chronic infectious disease caused by Mycobacterium leprae (M. leprae). In lepromatous leprosy (LL), skin macrophages, harboring extensive bacterial multiplication, gain a distinctive foamy appearance due to increased intracellular lipid load. To determine the mechanism by which M. leprae modifies the lipid homeostasis in host cells, an in vitro M. leprae infection system, using human macrophage precursor THP-1 cells and M. leprae prepared from the footpads of nude mice, was employed. RNA extracted from skin smear samples of patients was used to investigate host gene expressions before and after multidrug therapy (MDT). We found that a cluster of peroxisome proliferator-activated receptor (PPAR) target genes associated with adipocyte differentiation were strongly induced in M. leprae-infected THP-1 cells, with increased intracellular lipid accumulation. PPAR-δ and PPAR-γ expressions were induced by M. leprae infection in a bacterial load-dependent manner, and their proteins underwent nuclear translocalization after infection, indicating activation of PPAR signaling in host cells. Either PPAR-δ or PPAR-γ antagonist abolished the effect of M. leprae to modify host gene expressions and inhibited intracellular lipid accumulation in host cells. M. leprae-specific gene expressions were detected in the skin smear samples both before and after MDT, whereas PPAR target gene expressions were dramatically diminished after MDT. These results suggest that M. leprae infection activates host PPAR signaling to induce an array of adipocyte differentiation-associated genes, leading to accumulation of intracellular lipids to accommodate M. leprae parasitization. Certain PPAR target genes in skin lesions may serve as biomarkers for monitoring treatment efficacy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes / cytology
  • Adipocytes / metabolism
  • Adipocytes / microbiology
  • Animals
  • Cell Differentiation
  • Foam Cells / metabolism
  • Foam Cells / microbiology*
  • Humans
  • Leprostatic Agents / therapeutic use
  • Leprosy / drug therapy
  • Leprosy / genetics
  • Leprosy / metabolism*
  • Leprosy / microbiology
  • Lipid Metabolism
  • Macrophages / metabolism
  • Macrophages / microbiology*
  • Mice
  • Mice, Nude
  • Mycobacterium leprae / drug effects
  • Mycobacterium leprae / physiology*
  • PPAR delta / genetics
  • PPAR delta / metabolism*
  • PPAR gamma / genetics
  • PPAR gamma / metabolism*
  • Skin / metabolism
  • Skin / microbiology

Substances

  • Leprostatic Agents
  • PPAR delta
  • PPAR gamma

Grants and funding

This research was supported by Japan Agency for Medical Research and Development (AMED) under Grant Number (JP17fk0108303j, N.I.) and Grant Number JP19fk0108064j, and Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (Number 16K19204, Y.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.